SCHEMBL7704809

SCHEMBL7704809

CC1Oc2ccc(CN(Cc3c(F)cccc3Cl)C(=O)OC(C)(C)C)cc2NC1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.41
SMYD3 Q9H7B4 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
KDR P35968 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
POLB P06746 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708241 0.91 ALDH1A1 (0.35) PARP1ALDH1A1HSD17B10LMNATSHR
SCHEMBL7708088 0.87 PARP1 (0.47) PARP1SMYD3ALDH1A1PDE3BPDE3A
SCHEMBL7708056 0.87 PARP1 (0.47) PARP1SMYD3ALDH1A1KDRALOX15
SCHEMBL6308969 0.86 PARP1 (0.46) PARP1SMYD3ALDH1A1PDE3BPDE3A
SCHEMBL7713256 0.86 PARP1 (0.48) PARP1SMYD3ALDH1A1PDE3BPDE3A
SCHEMBL7711139 0.86 PARP1 (0.48) PARP1SMYD3ALDH1A1KDRALOX15
SCHEMBL7713425 0.86 PARP1 (0.44) PARP1SMYD3PDE3BPDE3AALOX15
SCHEMBL6302723 0.85 PARP1 (0.47) PARP1SMYD3ALDH1A1KDRALOX15
SCHEMBL7713340 0.85 PARP1 (0.47) PARP1SMYD3ALDH1A1PDE3BPDE3A
SCHEMBL7708149 0.85 PARP1 (0.45) PARP1SMYD3ALDH1A1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed